References
- Gurbel PA, Jeong YH, Navarese EP, et al. Platelet-mediated thrombosis: from bench to bedside. Circ Res. 2016;118:1380–1391. DOI:10.1161/CIRCRESAHA.115.307016
- Hirsh J. Hyperactive platelets and complications of coronary artery disease. N Engl J Med. 1987;316:1543–15447.
- Gurbel PA, Bliden KP, Hiatt BL, et al. Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation. 2003;107(23):2908–2913. DOI:10.1161/01.CIR.0000072771.11429.83
- Tantry US, Bonello L, Aradi D, et al.Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding. J Am Coll Cardiol. 2013;62:2261–2273.
- Sibbing D, Aradi D, Alexopoulos D, et al. Updated expert consensus statement on platelet function and genetic testing for guiding P2Y12 receptor inhibitor treatment in percutaneous coronary intervention. JACC: Cardiovasc Interv. 2019;12(16):1521–1537. DOI:10.1016/j.jcin.2019.03.034
- Born GV. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 1962;194(4832):927–929. DOI:10.1038/194927b0.
- Rana A, Westein E, Niego B. Hagemeyer CE Shear dependent platelet aggregation: mechanisms and therapeutic opportunities. Front Cardiovasc Med. 2019;6:141.
- Solen K, Sukavaneshvar S, Zheng Y, et al. Mohammad F A light-scattering instrument for detecting thromboemboli in blood. J Biomed Optics. 2003;8:70–79.
- Gurbel PA, Tantry US, Bliden KP, et al. Clinical validation of AggreGuide A-100 ADP, a novel assay for assessing the antiplatelet effect of oral P2Y12 antagonists. J Thromb Thrombolysis. 2021;52(1):272–280. DOI:10.1007/s11239-021-02498-0.
- Aggreguide A-100 AA assay package insert. Accessed 10 Dec 2022. https://www.aggredyne.com/site/wp-conte nt/uploa ds/2020/07/AA-Assay-A-100-LBL- 0030-C-Print-Version.pdf.
- Aggreguide A-100 ADP assay evaluation. Accessed on 10 Dec 2022. https://clinicaltrials.gov/ct2/show/NCT02112539.
- CLSI. Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline—third edition. CLSI document C28-A3. Wayne; PA, USA: Clinical and Laboratory Standards Institute; 2008.
- Study of AggreGuide A-100 (ADP) assay. https://clinicaltrials.gov/ct2/show/NCT03111420. Accessed 10 Dec 2022